In-Vitro Diagnostics Market Global Industry Trends, Growth, Share, Size and Forecast Research Report 2027
Market Size – USD 69.63 billion in 2019, Market Growth – CAGR of 4.6%, Market trends – The rise in the trend of personalized medicine.
According to the current analysis of Emergen Research, the global In-Vitro Diagnostics Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%. Significant growth in incidences of In-Vitro Diagnostics is observed across emerging countries together with increasing elderly population. Also, poor standard of living due to stressful work-life balance resulting in the overstimulation of immune system.
Rising advancements in biosimilars and robust pipeline of biologic products are expressively enhancing the availability of safe and efficient psoriatic arthritis treatment. High incidence of psoriatic arthritis is extensively experienced by those patients who are already suffering from plague psoriasis. These scenarios are actively contribute to the industry growth of In-Vitro Diagnostics treatment and therefore, demand for drugs linked with this treatment are also likely to escalate in the forecast period.
Key players in the market include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies
Browse complete report description and visit our website @ https://www.emergenresearch.com/industry-report/in-vitro-diagnostics-market
Regional Scope: North America; Europe; Asia Pacific; Central & South America; MEA
Product Outlook (Revenue, USD Billion; 2017-2027)
- Reagents & Kits
- Instruments
- Fully Automated Instruments
- Semi-Automated Instruments
- Data Management Software
- Services
Devices Outlook (Revenue, USD Billion; 2017-2027)
- Reusable IVD Devices
- Disposable IVD Devices
Application Outlook (Revenue, USD Billion; 2017-2027)
- Cancer
- Infectious Diseases
- Diabetes
- Gastrointestinal Disease
- Autoimmune Diseases
- Cardiac Disease
- Drug Testing /Pharmacogenomics
- HIV/AIDS
- Nephrological Disease
- Other
Technique Outlook (Revenue, USD Billion; 2017-2027)
- Immunoassay
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Hematology
- Coagulation and Hemostasis
- Urinalysis
- Other IVD Technologies
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Diagnostic Laboratories
- Homecare Settings
- Others
North America accounted for the largest market share of approximately, 37.2% in the global In-Vitro Diagnostics market in 2019 primarily due to growing incidences of chronic asthma and rhinosinusitis symptoms along with competent infrastructure and favorable reimbursement scenarios. Owing to such promising market drivers, the North American market is anticipated to grow significantly through the forecast period.
Thank you for reading our report. For further information or queries about the report or customization options, please get in touch with us. We will ensure your report is tailored according to your requirements.
